RAS PROTEINS IN T CELL ACTIVATION AND DIFFERENTIATION
T 细胞激活和分化中的 RAS 蛋白
基本信息
- 批准号:6372712
- 负责人:
- 金额:$ 11.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-15 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from application abstract): The long term objective of
the proposed research is to characterize how the potency of the T cell
receptor (TCR) signals affects the activity of the Ras family of small
GTPases. 'I'CR signals will be viewed by altering the contribution of the CD45
protein tyrosine phosphatase and by using ligands of varying affinities for
the TCR. Thee studies will explore the hypothesis that small GTPases Ras and
related protein Rapl do not act in isolation from each other but rather remain
in close functional relationships which may effectively integrate and modify
signal transduction events induced by the TCR complex. The applicant
hypothesizes that depending on the isoform of CD 45 and the strength of the T
cell receptor ligation, either antagonistic or synergistic arrangements
between Ras and Rap1 are included, and that these different relationships
which may influence lymphocyte behaviors such as T cell early development,
differentiation of matured cells into Th1 or 'I'h2 helper subsets, and the
generation of memory T cell pools. In aim 1, the biochemical and functional
experiments will examine the effect s of single CD45 isoforms on Ras and Rapl
with respect to their immediate downstream targets and the direct upstream
stimulators, the Raf kinases and the guanine nucleotide exchange factors
(GEFs) respectively. Because individual.. CD4: isoforms are believed to
differentially modify responsiveness of T cells to TCR induction information
obtained in these studies will model approaches in aim 2 in which the effects
of TCR stimulation with high affinity wild type peptide or low affinity
altered peptide ligand, will be analyzed. In particular, following, these
stimulations, the applicant will evaluate biochemical activities of Ras and
Rapl, and examine functional properties of RAP1 to enhance or suppress Ras-
signaling effects on mitogen activated protein kinase (MPK). The applicant
plans to eventually deliver the dominant negative or constitutive active
mutants of Ras or Rap1 into primary T cells and to test their potential to
interfere with the functional polarization processes occurring during immune
response. Understanding the molecular mechanisms controlling the activation
and differentiation of naive T helper cells is crucial with regard to a
variety of immunological conditions including allergic, infectious and
autoimmune diseases. In addition, basic studies on the regulation of T
lymphocytes by small GTPases have broad applicability to the field of cancer
pathogenesis.
描述(改编自申请摘要):长期目标
拟议的研究旨在表征 T 细胞的效力如何
受体 (TCR) 信号影响小分子 Ras 家族的活性
GT酶。 'I'CR 信号将通过改变 CD45 的贡献来查看
蛋白酪氨酸磷酸酶并通过使用不同亲和力的配体
TCR。这些研究将探讨小 GTPases Ras 和
相关蛋白 Rapl 不会彼此孤立地发挥作用,而是保持不变
密切的功能关系可以有效地整合和修改
TCR 复合物诱导的信号转导事件。 申请人
假设取决于 CD 45 的亚型和 T 的强度
细胞受体连接,拮抗或协同排列
Ras 和 Rap1 之间的关系都包含在内,并且这些不同的关系
这可能会影响淋巴细胞的行为,例如 T 细胞的早期发育,
成熟细胞分化为 Th1 或 'I'h2 辅助亚群,以及
记忆T细胞池的产生。 在目标 1 中,生化和功能
实验将检查单个 CD45 同工型对 Ras 和 Rapl 的影响
就其直接下游目标和直接上游而言
刺激剂、Raf 激酶和鸟嘌呤核苷酸交换因子
(全球环境基金)。因为个体.. CD4:亚型被认为
差异性地改变 T 细胞对 TCR 诱导信息的反应
这些研究中获得的结果将模拟目标 2 中的方法,其中效果
高亲和力野生型肽或低亲和力的 TCR 刺激
将分析改变的肽配体。特别是,以下这些
刺激,申请人将评估Ras和的生化活性
Rapl,并检查 RAP1 的功能特性以增强或抑制 Ras-
对丝裂原激活蛋白激酶(MPK)的信号传导作用。 申请人
计划最终提供主导消极或本构积极
Ras 或 Rap1 突变体进入原代 T 细胞并测试其潜力
干扰免疫过程中发生的功能极化过程
回复。了解控制激活的分子机制
幼稚 T 辅助细胞的分化对于
各种免疫性疾病,包括过敏性、感染性和
自身免疫性疾病。 此外,T调控的基础研究
小 GTP 酶产生的淋巴细胞在癌症领域具有广泛的适用性
发病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jan Czyzyk其他文献
Jan Czyzyk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jan Czyzyk', 18)}}的其他基金
The Role of Anti-Serpin B13 Autoantibody as a Biomarker of Slower Progression in Type 1 Diabetes Mellitus
抗丝氨酸蛋白酶抑制剂 B13 自身抗体作为 1 型糖尿病进展缓慢的生物标志物的作用
- 批准号:
9336062 - 财政年份:2016
- 资助金额:
$ 11.59万 - 项目类别:
RAS PROTEINS IN T CELL ACTIVATION AND DIFFERENTIATION
T 细胞激活和分化中的 RAS 蛋白
- 批准号:
6189684 - 财政年份:2000
- 资助金额:
$ 11.59万 - 项目类别:
RAS PROTEINS IN T CELL ACTIVATION AND DIFFERENTIATION
T 细胞激活和分化中的 RAS 蛋白
- 批准号:
6532636 - 财政年份:2000
- 资助金额:
$ 11.59万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 11.59万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 11.59万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 11.59万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 11.59万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 11.59万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 11.59万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 11.59万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 11.59万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 11.59万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 11.59万 - 项目类别:
Discovery Grants Program - Individual